Monozygotic twins discordant for neurofibromatosis 1. 2010

Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

We present monozygotic twins discordant for the autosomal dominant disorder neurofibromatosis type 1 (NF1). The affected twin was diagnosed with NF1 at age 12, based upon accepted clinical criteria for the disorder. Both twins were re-examined at ages 35 and 57, at which times the unaffected twin continued to show no clinical manifestations of NF1. Short tandem repeat marker (STR) genotyping at 10 loci on chromosome 17 and 10 additional loci dispersed across the genome revealed identical genotypes for the twins, confirming their monozygosity. The affected twin has three children, two of whom also have NF1, while the unaffected twin has two children, both unaffected. Using lymphoblastoid, fibroblast, and buccal cell samples collected from both twins and from other family members in three generations, we discovered a pathogenic nonsense mutation in exon 40 of the NF1 gene. This mutation was found in all cell samples from the affected twin and her affected daughter, and in lymphoblastoid and buccal cells but not fibroblasts from the unaffected twin. We also found a novel non-synonymous change in exon 16 of the NF1 gene that was transmitted from the unaffected mother to both twins and co-segregated with the pathogenic mutation in the ensuing generation. All cells from the twins were heterozygous for this apparent exon 16 polymorphism and for single nucleotide polymorphisms (SNPs) within 2.5 kb flanking the site of the exon 40 nonsense mutation. This suggests that the NF1 gene of the unaffected twin differed in the respective lymphoblastoid cells and fibroblasts only at the mutation site itself, making post-zygotic mutation leading to mosaicism the most likely mechanism of phenotypic discordance. Although the unaffected twin is a mosaic, the distribution of the mutant allele among different cells and tissues appears to be insufficient to cause overt clinical manifestations of NF1.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009030 Mosaicism The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
D009456 Neurofibromatosis 1 An autosomal dominant inherited disorder (with a high frequency of spontaneous mutations) that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene (GENES, NEUROFIBROMATOSIS 1) on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. (From Adams et al., Principles of Neurology, 6th ed, pp1014-18) There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras (RAS PROTEINS). Peripheral Neurofibromatosis,Recklinghausen Disease of Nerve,von Recklinghausen Disease,Cafe-au-Lait Spots with Pulmonic Stenosis,Molluscum Fibrosum,NF1 (Neurofibromatosis 1),Neurofibromatosis I,Neurofibromatosis Type 1,Neurofibromatosis Type I,Neurofibromatosis, Peripheral Type,Neurofibromatosis, Peripheral, NF 1,Neurofibromatosis, Peripheral, NF1,Neurofibromatosis, Type 1,Neurofibromatosis, Type I,Pulmonic Stenosis with Cafe-au-Lait Spots,Recklinghausen Disease, Nerve,Recklinghausen's Disease of Nerve,Recklinghausens Disease of Nerve,Watson Syndrome,von Recklinghausen's Disease,Cafe au Lait Spots with Pulmonic Stenosis,Neurofibromatoses, Peripheral,Neurofibromatoses, Type I,Neurofibromatosis, Peripheral,Peripheral Neurofibromatoses,Pulmonic Stenosis with Cafe au Lait Spots,Syndrome, Watson,Type 1 Neurofibromatosis,Type 1, Neurofibromatosis,Type I Neurofibromatoses,Type I, Neurofibromatosis,von Recklinghausens Disease
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004200 Diseases in Twins Disorders affecting TWINS, one or both, at any age. Diseases in Twin,Twin, Diseases in,Twins, Diseases in,in Twin, Diseases,in Twins, Diseases
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females

Related Publications

Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
November 1990, Obstetrics and gynecology,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
June 2007, Twin research and human genetics : the official journal of the International Society for Twin Studies,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
June 2011, Human mutation,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
February 1976, Journal of medical genetics,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
September 1988, Nihon Sanka Fujinka Gakkai zasshi,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
February 1955, A.M.A. American journal of diseases of children,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
January 2004, Plastic and reconstructive surgery,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
September 2011, Pediatrics,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
November 1989, Neurology,
Lee Kaplan, and Rosemary Foster, and Yiping Shen, and Dilys M Parry, and Mary L McMaster, and Melanie Collins O'Leary, and James F Gusella
April 2012, Journal of perinatology : official journal of the California Perinatal Association,
Copied contents to your clipboard!